ISHITA DRUGS & INDUSTRIES LTD. Share Price

BSE: 524400

S Cap

₹ 74.95

+₹2.65 (3.67%)

Last updated 11 Aug, 2026, 15:29 IST

ISHITA DRUGS & INDUSTRIES LTD. Share Price Today

As of 11 Aug 2026, ISHITA DRUGS & INDUSTRIES LTD. share price is ₹74.95. The stock opened at ₹75.40, compared to its previous close of ₹72.30. During today's trading session, ISHITA DRUGS & INDUSTRIES LTD. share price moved in the range of ₹72.50 to ₹75.40, with an average price of ₹73.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹66.00 and a high of ₹90.85.

₹72.50

3.67% up today

₹75.40

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 0.25 % in last 1 month

ISHITA DRUGS & INDUSTRIES LTD. Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,20,486+₹20,486 (+4.10%)

3 Year

₹5,72,137+₹72,137 (+14.43%)

5 Year

₹9,05,193+₹4,05,193 (+81.04%)

₹57.84₹86.76

Circuit Low

Circuit High

₹66.00₹90.85

52-Week Low

52-Week High

Circuit

₹57.84

₹86.76

52-week

₹66.00

₹90.85

About ISHITA DRUGS & INDUSTRIES LTD.

ISIN

INE806D01016

Sector Market Cap

₹ 21.62 Cr

Ishita Drugs and Industries Limited is a manufacturer of various active pharma ingredients (APIs) (bulk actives and their salts), drug intermediates, excipients, and fine chemicals. The Company's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, and methyl iodide. The Company has three manufacturing facilities located in the state of Gujarat.

ISHITA DRUGS & INDUSTRIES LTD. Financial Highlights

Revenue: ISHITA DRUGS & INDUSTRIES LTD. reported revenue of ₹15.13 crore in FY26 vs ₹15.34 crore in FY25. It showed a decrease of 1.37% on a yearly basis.
Operating Profit: ISHITA DRUGS & INDUSTRIES LTD. reported an operating profit of ₹1.08 crore in FY26 vs ₹1.16 crore in FY25. It showed a decrease of 6.90% on a year-on-year basis.
Net Profit: ISHITA DRUGS & INDUSTRIES LTD. reported a net profit of ₹0.78 crore in FY26 vs ₹0.87 crore in FY25. It showed a decrease of 10.34% on a yearly basis.

ISHITA DRUGS & INDUSTRIES LTD. Quarterly Result Highlights

ISHITA DRUGS & INDUSTRIES LTD. reported revenue of ₹3.19 crore in Jun 2026, compared with ₹3.28 crore in Mar 2026, representing a decrease of 2.74% on a quarter-on-quarter (QoQ) basis.
ISHITA DRUGS & INDUSTRIES LTD. reported an operating profit of ₹0.30 crore in Jun 2026, compared with ₹0.28 crore in Mar 2026, representing an increase of 7.14% on a quarter-on-quarter (QoQ) basis.
ISHITA DRUGS & INDUSTRIES LTD. reported a profit of ₹0.23 crore in Jun 2026, compared with ₹0.18 crore in Mar 2026, reflecting an increase of 27.78% on a QoQ basis.
The earnings per share (EPS) of ISHITA DRUGS & INDUSTRIES LTD. stood at ₹2.90 during Jun 2026.

Know more

Promoters

50.04%

FII

0.00%

Other DII

0.00%

Retail and other

49.96%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Sep 2025	0.00%
Dec 2025	0.00%
Mar 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

21.62

P/E

30.64

P/B

1.87

ROE

6.73%

D/E

0.01

ROCE

9.78%

Div. Yield

0.00%

EPS(TTM)

2.60

Turnover

1.16

EV/EBITDA

15.82

Net Margin

0.00%

Op. Margin

0.00%

ROA

6.19%

Quick Ratio

0.00

Curr. Ratio

10.14

Mkt Cap Cr

21.62

P/E

30.64

P/B

1.87

ROE

6.73%

D/E

0.01

ROCE

9.78%

Div. Yield

0.00%

EPS(TTM)

2.60

Turnover

1.16

EV/EBITDA

15.82

Net Margin

0.00%

Op. Margin

0.00%

ROA

6.19%

Quick Ratio

0.00

Curr. Ratio

10.14

Based on fundamentals, this stock's

Performance

Very Poor

Ishita Drugs has not beaten FD return of 7%

Valuation

Overvalued

Ishita Drugs appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,68,530.00	38.67	5.61	13.74%	0.61	17.33%	93.24	0.82%	0.48	10.90
Divis Laboratories	2,19,675.00	75.10	13.11	15.32%	0.00	19.56%	629.49	0.36%	0.55	98.19
Torrent Pharmaceuticals	1,86,970.00	86.72	22.23	25.49%	1.69	13.85%	222.76	0.69%	0.49	58.70
Cipla	1,17,945.00	35.15	3.43	11.27%	0.00	14.95%	423.36	0.89%	0.45	43.52
Zydus Lifesciences	1,11,790.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,04,020.00	18.74	4.63	23.76%	0.04	24.88%	659.05	0.79%	0.57	129.18
Mankind Pharma	1,00,688.00	48.70	6.18	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Laurus Labs	1,00,822.00	92.47	19.02	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Dr. Reddy's Laboratories	96,601.20	30.34	2.54	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	95,600.00	25.76	2.52	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

ISHITA DRUGS & INDUSTRIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹15.00	₹15.19	₹12.07	₹14.09
Other Income	₹0.34	₹0.28	₹0.20	₹0.11
Total Revenue	₹15.33	₹15.47	₹12.27	₹14.20
Total Expenses	₹14.18	₹14.48	₹11.49	₹13.15
Profit Before Tax	₹1.16	₹0.99	₹0.78	₹1.04
Tax	₹0.29	₹0.24	₹0.20	₹0.24
Profit After Tax	₹0.87	₹0.75	₹0.58	₹0.80
EPS - Basic	₹2.90	₹2.50	₹1.93	₹2.69
EPS - Diluted	₹2.90	₹2.50	₹1.93	₹2.69

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹1.16	₹0.99	₹0.78	₹1.04
Income before WC changes	₹1.00	₹0.91	₹0.76	₹1.09
Change in Assets	-₹4.86	₹1.84	-₹2.07	₹0.77
Change in Liabilities	₹0.22	-₹0.63	-₹1.59	₹1.21
Change in WC	-₹4.64	₹1.21	-₹3.66	₹1.99
Cash flow from Operations	-₹3.64	₹2.12	-₹2.90	₹3.08
Cash flow from Investing	-₹0.67	₹0.13	₹0.59	-₹0.93
Cash flow from Financing	₹4.33	-₹0.87	₹1.05	₹0.00
Total Cash Flow	₹0.02	₹1.38	-₹1.25	₹2.14
Cash (Start of the year)	₹4.81	₹3.43	₹4.68	₹2.54
Cash (End of the year)	₹4.83	₹4.81	₹3.43	₹4.68

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹1.31	₹1.15	₹1.23	₹1.21
Current Assets	₹14.98	₹9.66	₹10.18	₹10.05
Total Assets	₹16.30	₹10.81	₹11.41	₹11.25
Current Liabilities	₹5.40	₹0.87	₹2.21	₹2.63
Net Current Asset	₹9.58	₹8.79	₹7.96	₹7.42
Non-Current Liabilities	₹0.10	₹0.02	₹0.02	₹0.03
Equity Capital	₹10.79	₹9.92	₹9.17	₹8.60
Total Equity & Liabilities	₹16.30	₹10.81	₹11.41	₹11.25